Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Spermatogenesis-associated protein 31A1 (SPATA31A1) is a protein coding gene located on chromosome 9, highly expressed in testis, and believed to play a role in spermatogenesis and cell differentiation. In humans, SPATA31A1 is part of a fast-evolving gene family that expanded its functions to include UV damage sensing and DNA repair, especially in response to environmental stressors such as sunlight exposure. Overexpression of SPATA31A1 in fibroblast cells leads to premature senescence and alters aging-related transcriptional pathways, suggesting a role in cellular and organismal aging. Copy number variation of SPATA31 genes correlates negatively with human longevity, with long-lived individuals having fewer copies. Although associated with certain clinical conditions such as foramen magnum meningioma and Bardet-Biedl Syndrome 15, no direct causative or therapeutic roles have been established. Currently, SPATA31A1 is not considered a druggable target nor associated with approved pharmacological interventions.
None (no drug mechanisms documented for this molecule)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Spermatogenesis-associated protein 31A1 (SPATA31A1).